Rv0233 Ribonucleotide-diphosphate reductase subunit beta (EC 1.17.4.1)

Summary

Symbol Product Feature Type Start End Strand Length AA Length is TF
Rv0233 nrdB Ribonucleotide-diphosphate reductase subunit beta (EC 1.17.4.1) CDS 278585 279529 + 945 314 FALSE

Rv0233 (Ribonucleotide-diphosphate reductase subunit beta (EC 1.17.4.1)) is predicted to be co-regulated in modules bicluster_0089 with residual 0.51 and bicluster_0560 with residual 0.59.

This regulation is possibly mediated by two de-novo identified cis-regulatory motifs in each module with e-values , 0.83 and 9.30 for bicluster_0089 and 0.01 and 21.00 for bicluster_0560 respectively.

These modules are enriched for following go terms: folic acid-containing compound biosynthe..., pteridine-containing compound biosynthet..., coenzyme metabolic process, cellular modified amino acid biosyntheti....

This gene is found to be for growth on cholesterol.

Mutant available?: Yes

Last update: 10/16/2017 - 17:54
BEI Mutant Available BEI Mutant ID BEI MT Number BEI Target ID Order from BEI
Yes NR-14760 MT0244 74
Product (LegacyBRC) Product (RefSeq)
PROBABLE RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE [BETA CHAIN] NRDB [RIBONUCLEOTIDE REDUCTASE SMALL CHAIN] ribonucleotide-diphosphate reductase subunit beta
Operon # Operon
161 -
Locus Tuberculist Genome View

Tuberculist

Quickview
Locus Tag KEGG Pathways

KEGG

Purine metabolism

65
Total items in this category:  

KEGG

Pyrimidine metabolism

41
Total items in this category:  

KEGG

Metabolic pathways

601
Total items in this category:  
BioCyc Gene Page Cellular Overview Map
Link to STRING STRING Network

STRING

GI Number Protein ID Blast Conserved Domains
15607374 NP_214747.1 Run
GO:0005829

cytosol

cytosol

Details: 
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
GO Category: 
cellular_component
371
Total items in this category:  
No TFOE experiment results were found

Quantitative Proteomics Data

t-test p-value Cholesterol/Glycerol Ratio
0.790000 1.42

How essentiality calculations were done?

The relative representation of each mutant was determined by calculating the fold change (sequence reads/insertion in cholesterol divided by sequence reads/insertion in glycerol) for each gene. Statistical significance was determined by t-test. Each insertion site in each replicate sample was treated as a separate data point. The hyperbola used for defining genes specifically required for growth in cholesterol was defined by the formula, y = 3.8/x+0.7. Genes above this line are annotated as required for growth on cholesterol.

TRIP log2 fold abundance change

reports the log2 abundance fold change of each TFI strain, relative to no induction, in absence or presence of drug, averaged across experimental replicates. Also reported are the accompanying z-scores and two-sided t-test p-values for each TFI strain under each condition. Please refer to Ma et al., 2020, Nature Microbiology for more information.

p-value Untreated:
p-value INH: